Quince Therapeutics, Inc.
QNCX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001662774
No open-market purchases or sales by Quince Therapeutics, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $4.74M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Quince Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- −4 vs. Q1 2023
- Shares held
- 8.98M
- +1.30M (+16.9%) vs. Q1 2023
- Total value
- $13.5M
- +$1.53M (+12.8%) vs. Q1 2023
- New holders
- 5
- 7 more added
- Sold out
- 9
- 10 more reduced
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting QNCX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $4.74M |
| Q1 2026 | 46 | $1.44M |
| Q4 2025 | 67 | $67.5M |
| Q3 2025 | 45 | $19.2M |
| Q2 2025 | 41 | $12.5M |
| Q1 2025 | 36 | $6.96M |
| Q4 2024 | 35 | $9.55M |
| Q3 2024 | 33 | $4.04M |
| Q2 2024 | 43 | $4.68M |
| Q1 2024 | 46 | $7.71M |
| Q4 2023 | 44 | $7.83M |
| Q3 2023 | 42 | $8.40M |
| Q2 2023 | 40 | $13.5M |
| Q1 2023 | 45 | $12.0M |
| Q4 2022 | 50 | $3.44M |
| Q3 2022 | 61 | $12.4M |
| Q2 2022 | 70 | $26.0M |
| Q1 2022 | 88 | $99.5M |
| Q4 2021 | 102 | $242.8M |
| Q3 2021 | 131 | $1.76B |
| Q2 2021 | 105 | $982.9M |
| Q1 2021 | 91 | $673.5M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Quince Therapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BNP Paribas Arbitrage, SA | 59 | $89 | 0.00% | −588−90.9% | Reduced |
| Westside Investment Management, Inc. | 75 | $113 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 100 | $151 | 0.00% | 00.0% | Unchanged |
| Financial Avengers, Inc. | 100 | $151 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 154 | $232 | 0.00% | +7+4.8% | Added |
| Allworth Financial LP | 267 | $402 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 277 | $416 | 0.00% | 00.0% | Unchanged |
| Financial Perspectives, Inc | 310 | $467 | 0.00% | 00.0% | Unchanged |
| JDM Financial Group LLC | 340 | $512 | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 394 | $592 | 0.00% | +394 | New |
| JPMorgan Chase & Co | 469 | $706 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 478 | $1.00K | 0.00% | +478 | New |
| UBS Group AG | 912 | $1.37K | 0.00% | +587+180.6% | Added |
| Parallel Advisors, LLC | 2,376 | $3.58K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 5,165 | $7.77K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 7,249 | $10.9K | 0.00% | −2,445−25.2% | Reduced |
| Brinker Capital Investments, LLC | 10,136 | $15.3K | 0.00% | 00.0% | Unchanged |
| Orion Portfolio Solutions, LLC | 10,136 | $15.3K | 0.00% | 00.0% | Unchanged |
| Westmount Partners, LLC | 10,148 | $15.3K | 0.01% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 11,013 | $16.6K | 0.00% | 00.0% | Unchanged |
| Cohen Lawrence B | 11,126 | $16.7K | 0.01% | 00.0% | Unchanged |
| Strategic Blueprint, LLC | 12,200 | $18.4K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 43,858 | $66.0K | 0.00% | +3,436+8.5% | Added |
| Intellectus Partners, LLC | 53,527 | $80.6K | 0.02% | +53,527 | New |
| Bridgeway Capital Management, LLC | 55,000 | $82.8K | 0.00% | −55,000−50.0% | Reduced |
| State Street Corp | 56,611 | $85.2K | 0.00% | −800−1.4% | Reduced |
| Millennium Management LLC | 61,407 | $92.4K | 0.00% | −186,606−75.2% | Reduced |
| Two Sigma Investments, LP | 69,529 | $104.6K | 0.00% | −57,557−45.3% | Reduced |
| Susquehanna International Group, LLP | 112,772 | $169.7K | 0.00% | −12,754−10.2% | Reduced |
| Bank of America Corp | 162,939 | $245.2K | 0.00% | +147,691+968.6% | Added |
| Geode Capital Management, LLC | 187,162 | $281.7K | 0.00% | +50,076+36.5% | Added |
| Alphabet Inc. | 189,122 | $285.6K | 0.02% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 191,189 | $287.7K | 0.00% | −213,811−52.8% | Reduced |
| Knightsbridge Asset Management, LLC | 228,605 | $344.0K | 0.11% | +228,605 | New |
| Renaissance Technologies LLC | 288,700 | $434.0K | 0.00% | +58,900+25.6% | Added |
| BlackRock Inc. | 339,715 | $511.3K | 0.00% | +15,809+4.9% | Added |
| Vanguard Group Inc | 893,291 | $1.34M | 0.00% | 00.0% | Unchanged |
| EPIQ Capital Group, LLC | 933,180 | $1.40M | 0.74% | −25,289−2.6% | Reduced |
| BML Capital Management, LLC | 1,411,839 | $2.12M | 1.91% | +1,411,839 | New |
| Tang Capital Management LLC | 3,613,280 | $5.44M | 0.80% | −6,720−0.2% | Reduced |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −46,840−100.0% | Sold out |
| Hennion & Walsh Asset Management, Inc. | 0 | $0 | 0.00% | −31,061−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −22,321−100.0% | Sold out |
| Quantamental Technologies LLC | 0 | $0 | 0.00% | −10,867−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −1,050−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −801−100.0% | Sold out |
| Ten Capital Wealth Advisors, LLC | 0 | $0 | 0.00% | −163−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −32−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −98−100.0% | Sold out |
| Householder Group Estate & Retirement Specialist, LLC | – | – | – | – | Not filed |